Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size
J Breast Cancer
.
2020 Dec;23(6):672-673.
doi: 10.4048/jbc.2020.23.e62.
Authors
Laura Bender
1
,
Jean-Emmanuel Kurtz
1
,
Thierry Petit
1
,
Xavier Pivot
1
Affiliation
1
Department of Oncology, Institut de Cancérologie Strasbourg, Strasbourg, France.
PMID:
33408893
PMCID:
PMC7779725
DOI:
10.4048/jbc.2020.23.e62
No abstract available